Abstract
Background: Potential dietary strategies for controlling hyperphosphataemia include the use of protein sources with lower phosphorus bioavailability such as pulses and nuts, focus on phosphorus to protein ratios and the avoidance of all phosphate additives.
Methods: We conducted a controlled crossover feeding study in 8 haemodialysis (HD) patients to investigate the acute postprandial effect of a modified versus standard low phosphorus diet for one day on serum phosphate, potassium and intact parathyroid levels in prevalent HD patients. Each participant consumed the modified diet on one day and the standard diet on a second day one week apart. The modified diet included beef and less dairy, with a lower phosphorus to protein ratio, as well as plant-based protein, whole grains, pulses and nuts containing phytates which reduces phosphorus bioavailability. Both diets were tailored for each participant to provide 1.1g protein/kg ideal body weight. Participants provided fasting bloods before breakfast, a pre-prandial sample before the lunch time main meal and samples at one-hour intervals for the four hours after the lunch time main meal, for analysis of phosphate, potassium and intact parathyroid hormone (iPTH).
Results: At four hours post the lunch time main meal on each study day, individuals on the modified diet had serum phosphate readings 0.30 mmol/l lower than when on the standard diet (p-value = 0.015, 95% confidence interval [CI] -0.57, -0.04). The corresponding change in serum potassium at four hours was a decrease of 0.675 mmol/l (p-value = 0.011, CI -1.25, -0.10).
Conclusions: Decreases in both serum phosphate and serum potassium readings on a modified low phosphorus diet encourage further larger studies to explore the possibility of greater food choice and healthier plant-based diets in HD patients.
ClinicalTrials.gov registration: NCT04845724 (15/04/2021)
Keywords: Hyperphosphataemia, Phosphorus, Potassium, Diet, Haemodialysis
Introduction
Hyperphosphataemia is associated with increased mortality in end stage kidney disease 1, 2 . Higher phosphate levels, even within normal range are associated with increased mortality in those in the earlier stages of chronic kidney disease (CKD), and in patients with normal renal function 3– 8 .
Hyperphosphataemia is a major therapeutic target in the management of chronic kidney disease mineral and bone disorder (CKD MBD) and the use of phosphorus restricted diets is well established in the treatment of hyperphosphataemia in patients with CKD MBD 9 .
Few high quality trials have examined the impact of the dietary restriction of phosphorus and the evidence base is therefore weak 10 . Efforts to control total phosphorus intake may lead to the unnecessary restriction of higher fibre foods such as pulses and whole grains where the phosphorus is largely bound to phytate and thus unavailable for absorption 11 . Serum phosphate is not an ideal biomarker to use as an outcome measure in healthy or CKD populations. Circadian rhythm 12– 16 and fasting versus non fasting measurements 14, 15, 17– 19 can effect serum phosphate, challenging the interpretation of concentrations.
The mechanism of dietary phosphorus absorption remains poorly understood 20, 21 and we have limited data on postprandial changes in serum phosphate level 14, 22, 23 .
Following a review of emerging evidence, a national working group of Irish dietitians identified three strategies to improve the management of dietary phosphorus restriction; (1) the introduction of plant protein in the form of pulses, nuts and whole grains, (2) consideration of protein intake in terms of load as well as the phosphorus to protein ratio of different foods and (3) reduction of phosphate additive-containing foods 24, 25 . The rationale for this study was to examine the potential benefit of modifying the standard diet as used in clinical practice, to improve the quality and choice of foods allowed. This echoed a growing call internationally to liberalise the renal diet and to include vegetarian options, whilst acknowledging the need for careful monitoring of potential risks such as hyperkalaemia 26– 30 .
The feeding study described here was conducted to assess the effect of these proposed changes in a controlled environment over a short time period, providing insight into acute biochemical changes that occur in the postprandial phase.
Methods
Study design
We conducted a crossover study comparing the effect of two diets, a standard low phosphorus diet and a modified low phosphorus diet as described in Figure 1. The trial was registered at ClinicalTrials.gov on 15 th April 2021 (NCT04845724).
Figure 1. Study design and outcome assessments.

In total, five participants attending the first day were assigned to the modified diet, and three participants attending the following day received the standard diet. All participants returned the following week and received the opposite diet. On each day participants had fasting bloods on arrival, before the main midday meal and hourly following completion of the meal for 4 hours. Pre dialysis bloods were taken the following day before dialysis.
Ethical considerations
All participants provided informed written consent and the protocol was approved by the Clinical Research Ethics Committee (ECM 06/2021 PUB) and conformed with the 1975 Declaration of Helsinki, as revised in 2013.
Procedure
Participants were recruited from a university hospital dialysis unit. All patients on dialysis, three times per week, who attended Monday and Wednesday or Tuesday and Thursday, were included screened and assessed, resulting in a final sample size of 8. Figure 2 describes the recruitment process. The inclusion criteria were as follows: > 18 years of age; on dialysis for > 3 months and urinary outputs of < 200 ml/day by self-report. Exclusion criteria included history of diabetes mellitus, pre-dialysis serum phosphate > 2.5 mmol/L and serum potassium > 6.3 mmol/L on most recent routine monthly blood test; parathyroidectomy; history of calciphylaxis; and acute concurrent illness.
Figure 2. Study flow chart.

The study took place at a clinical research facility (CRF), in a university hospital close to the dialysis unit on the day between two dialysis sessions e.g. a patient who dialysed on Monday and Wednesday participated in the trial on a Tuesday. Each participant attended the (CRF) on two separate days, one week apart.
On the feeding days, participants were directly observed eating the standard low phosphorous diet or the modified low phosphorus diet, depending on the allocation.
The research dietitian (FB) provided the catering department with recipes and an individualised meal plan for each participant and supervised the weighing and plating of the meals. Assignment to each order e.g. standard followed by modified was not randomised. However catering staff were blinded to the identity of the participants and they decided on the order of the allocation e.g. standard diet on day 1 based on hospital food supplies. Participants and researchers were blinded to the allocation. However, once the meals were seen, it was obvious which contained the foods not usually permitted. Participants were asked to attend the CRF between 8 and 9 am having completed an overnight fast and were requested not to take their phosphate binders on the day of the study. Adherence was assessed by asking the participant to confirm whether or not they took their binders that morning. On the feeding day, participants were directly observed taking their meals and medications.
Upon arrival at the unit participants had an initial blood draw and breakfast was served between 8.45am and 9am. Two participants had a planned late arrival on both weeks and so were absent at the initial fasting blood draw. They were provided with a packed breakfast to have on the morning of the study prior to attending the research unit. All participants had a pre-prandial blood draw immediately before a lunch time main meal, which was served between 12 noon and 12.30pm. At each timepoint we took 2 samples, a serum (volume =4.9mL) for the potassium and phosphate analysis and an ethylenediaminetetraacetic acid (EDTA) sample (volume = 2.7mL) for the iPTH analysis. Bloods were collected at hourly intervals following completion of the lunch time main meal for 4 hours (1, 2, 3, 4 hours), and a light evening meal was provided prior to departure from the unit. This procedure was repeated the following week, where participants received the alternate diet plan. All serum samples were spun on a Nuve Bench top Centrifuge Model NF200 (spinning conditions unknown) and frozen at -80°C and subsequently analysed by the Biochemistry Department at the University Hospital. A pre dialysis sample was taken the day after the study. Phosphate was analysed using a photometric UV test for the quantitative determination of inorganic phosphorous in human serum using the ammonium molybdate method on a Beckman Coulter analyser 31, 32 .
Potassium was measured using the ion selective electrode module of Beckman Coulter AU analysers for the quantitative (indirect) determination of Potassium (K+) concentrations in human serum 33 .
iPTH was measured using the ARCHITECT Intact PTH assay is an in vitro chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of intact parathyroid hormone (PTH) in human serum on the ARCHITECT iSystem 34 .
As part of standard care monthly pre-dialysis blood samples were routinely taken and analysed in the same laboratory. Pre-dialysis phosphates from three months before and three months after the study were collected following the study to further contextualise the variability in baseline phosphate levels seen in the study.
Interventions
Table 1 describes the two diets. The substantial difference between prescribed the diets was at the lunch time main meal. The standard low phosphorus diet 35 main meal contained a higher proportion of foods with a higher phosphorus to protein ratio (salmon and dairy), and foods with higher phosphorus bioavailability (Madeira cake). The modified diet, representative of the proposed modified phosphorus diet used food of lower phosphorus to protein ratio such as beef and less dairy. When consuming the lunch time main meal, participants were advised to focus on the protein and phosphorus sources namely soup, beef, milk and nuts for the modified diet and salmon, milk and cake for the standard diet. Whilst in usual clinical practice, patients are advised to spread their dietary allowances over the day, on special occasions such as a wedding, for example, they are permitted to keep their allowances for a single meal. On this basis, 80% of the protein allowance was prescribed at the main meal. Food that was not consumed was weighed to ensure accurate assessment of food intake. Nutrient analysis was conducted using Nutritics software Research Edition v5.028 36 . using the McCance and Widdowson's composition of foods integrated dataset 37 . The potassium data was adjusted to account for leaching of potassium by double boiling the potatoes 38, 39 . Food samples were sent to the Public Analyst Laboratory, (Cork, Ireland) for analysis of total phosphorus. A spectrophotometric method was used in which the food samples were dry ashed in the presence of Zinc Oxide and total Phosphate content was measured colourimetrically as Molybdenum Blue at 880 nm 40 .
Table 1. Description of the standard low phosphorous diet and the modified low phosphorous diet.
| Standard Diet (S)
(based on current management) |
Modified Diet (M)
(based on proposed new diet sheet) |
|
|---|---|---|
| Light Breakfast | Tea & 15ml milk
100 ml orange juice 2 slices white bread with butter & marmalade |
Tea + 35ml milk
100 ml orange juice 1 slice white bread & 1 slice wholemeal toasted with butter & marmalade |
| Lunch Time Main Meal | 250 ml milk
*Steamed Salmon & white sauce 200g potatoes (double boiled) 100g carrots (boiled) 75g broccoli (boiled) 60g Madeira cake |
130 ml milk
Chickpea soup (100g pulses) *Roast Beef & gravy 200g potatoes (double boiled) 120g carrots (boiled) Meringue (20g) with strawberries (90g) & cream (35g) 25g peanuts |
| Evening Meal | Tea & 15ml milk
2 slices white bread with butter & jam Apple |
Tea & 35 ml milk
1 slice white bread 1 slice wholemeal bread with butter & jam |
*The salmon and beef portions were individualised to achieve a prescribed intake of 1.1g protein/kg ideal body weight per day for each participant. Approximately 30% dietary phosphorus in the modified diet came from foods with significant phytate content such as pulses, nuts and whole grains.
Participants were advised to revert to their regular dietary routine between the interventions. For the second feeding day (+ one week), participants were again asked to attend the CRF between 8 and 9 am having completed an overnight fast and were requested not to take their phosphate binders on the day of the study
Outcomes
Outcome measures were serum phosphate, potassium and iPTH, obtained: early morning (fasting), pre-prandial; at 1,2,3 and 4 hours post lunch time main meal consumption; and pre-dialysis the following day.
Statistical analysis
Given that this study served as a pilot, we did not calculate the sample size that would be required to reliably estimate the effect of the modified diet plan on patient outcomes. This follows from established best practices in pilot and feasibility studies 41 for which there is usually too much uncertainty in the various factors that are needed to make a sample size calculation robust. Our sample size justification is instead based on trying to recruit the largest possible sample given existing financial and pragmatic constraints. The effect of diet on serum phosphate and serum potassium levels was examined using a mixed effects model with diet and time as fixed effects and the patient as a random effect on the intercept as outlined by Bates et al., through use of the linear mixed effects regression (lmer) function contained within the lme4 package (version 1.1-21) 42 . An interaction term between time and diet was included in both models. The difference between mean serum levels following the standard and modified diets at each time point was tested using the general linear hypotheses function (ghlt) from the multcomp package (version 1.4-10) 43 . Differences in phosphorus content of foods between estimation methods were assessed using paired t-tests. All statistical analyses were performed using R version 3.6 44 .
Results
The baseline characteristics of the 8 enrolled participants are as follows: mean (SD) age was 66.6 (7.8) years ranging from 55.9 to 77.1 years. The mean (SD) body mass index (BMI) was 25.2 (4.0) kg/m 2 ranging from 17.9 to 31.3. The median (min, max) pre-prandial iPTH (ng/l) when consuming the standard diet was 294 (114, 663) and when consuming the modified diet was 377 (182, 775). Their dialysis vintage was 52 months ± 46.4, ranging from 19 to 164 months. There were seven males and one female. Four had a fistula and four had a line for dialysis access.
Overall, five participants commenced on the modified diet and three commenced on the standard diet. One male participant, whilst assigned to the modified diet, ate two wheat biscuits with 100mls of milk prior to arrival, and his early morning blood test was therefore omitted from the analysis. Participants took an average of 41 minutes to consume the standard diet lunch time main meal and 37 minutes to consume the modified diet lunch time main meal. Additionally, a study deviation from the protocol was noted for participant 8, who ate in a fast food restaurant after leaving the research unit; therefore his pre-dialysis sample for the following day was excluded from the analysis.
Compared to the standard low phosphorous diet, participants consumed a mean of 6.4g more protein per day (p = 0.185, 95% confidence interval [CI]; -3.9, 16.8); 156 mg less phosphorus (p = 0.029, 95% CI; -292.4, -20.9) and 88.6mg (2.3mmoles) less potassium (p = 0.41, 95% CI; -327.6, 150.3) on the modified low phosphorus diet ( Figure 3). On the modified low phosphorous diet participants consumed 7.0 g more fibre (p < 0.001, (95% CI; 5.8, 8.2).
Figure 3. Protein, phosphorus and potassium intake.
This figure describes the prescribed and consumed intake for each individual for the standard and modified lunch time main meal for ( A) protein, ( B) phosphorus and ( C) overall. Participants consumed less than prescribed.
The pre-prandial time point data indicated that participants when assigned to the modified diet had a mean starting phosphate serum reading of 0.291 mmol/L higher than when assigned to the standard diet ( Table 2 and Figure 4, (95% CI: 0.026, 0.556). Similar between group differences were seen in the fasting samples taken on arrival. The mean change in serum phosphate from pre-prandial levels was smaller at all four time points on the modified diet relative to the standard diet. Using a mixed effect model to describe the change in serum phosphate when switching from the standard to the modified diet, we observed significant mean reductions in serum phosphate at 3 hours, -0.32 mmol/L (95% CI: -0.58, -0.05), and at 4 hours, -0.30 mmol/L (95% CI -0.57, -0.04), Table 2. Figure 5 shows the phosphate data of each subject individually and Figure 4 shows the group mean for pre-prandial and each of the four hourly measurements of serum phosphate post-meal and describes an elevation in serum phosphate following consumption of the standard diet and an overall decrease in serum phosphate following consumption of modified diet.
Figure 4. Serum phosphate and potassium levels.
Post prandial serum readings for participants on standard low phosphorus diet S (black line with square) increased steadily over time and remained elevated the following day. This contrasted with an overall decrease in serum phosphate following consumption of the modified diet main meal (M; red line with circle). Points represent the mean ± standard deviation (SD).
Figure 5. Serum phosphate levels.
Figure 5 maps serum phosphate for each participant on the diet standard (S) in black and modified (M) in red at 6 time points pre-prandial, 1, 2, 3 and 4 hours after the meal and pre dialysis the following day.
Table 2. Mixed effects model output of serum phosphate and potassium.
| Time point | Mean
mmol/L |
Std. Error | p-value | 95% Confidence
Interval |
|
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Pre-prandial serum phosphate | 0.291 | 0.101 | 0.023 | 0.026 | 0.556 |
| 1 h serum phosphate | 0.078 | 0.101 | 0.970 | -0.187 | 0.342 |
| 2 h serum phosphate | 0.104 | 0.101 | 0.885 | -0.161 | 0.369 |
| 3 h serum phosphate | -0.315 | 0.101 | 0.010 | -0.580 | -0.050 |
| 4 h serum phosphate | -0.304 | 0.101 | 0.015 | -0.569 | -0.039 |
| Pre-dialysis serum phosphate | -0.104 | 0.104 | 0.901 | -0.379 | 0.171 |
| Pre-prandial serum potassium | 0.975 | 0.226 | 0.001 | 0.381 | 1.569 |
| 1 h serum potassium | 0.363 | 0.226 | 0.494 | -0.230 | 0.957 |
| 2 h serum potassium | 0.425 | 0.217 | 0.268 | -0.147 | 0.997 |
| 3 h serum potassium | -0.838 | 0.217 | 0.001 | -1.410 | -0.265 |
| 4 h serum potassium | -0.675 | 0.217 | 0.011 | -1.247 | -0.103 |
| Pre-dialysis serum potassium | -0.098 | 0.243 | 0.999 | -0.737 | 0.540 |
The mixed effect model describes the change in serum phosphate and potassium when switching from the standard to the modified diet. Fixed effects were diet and time point which included an interaction term, with patient included as a random effect.
To further evaluate the differences seen in pre-prandial baseline phosphate levels between the modified vs. the standard diet, we examined the pre-dialysis phosphate levels measured in routine testing in the three months prior to and following the study in a post hoc analysis. These measurements showed substantial within subject variability ( Figure 6) and were compatible with the differences in baseline values seen within participants in the study. The mean (SD) pre and post study, routinely measured serum phosphate levels were similar in those assigned initially to standard diet (1.75 ± 0.42 mmol/L, range 1.05 – 2.96) versus modified diet (1.78 ± 0.44 mmol/L, range 1.10 – 2.60) respectively, in keeping with our interpretation that the differences in the point estimates of baseline serum phosphate were consistent with the inherent variability in serum phosphate. The small sample size and high variability in iPTH analysis, made it impossible to interpret the data.
Figure 6. Within person variability in pre-dialysis serum phosphate.
This figure describes the variability, in the three months before and after the study in the three participants who started with the standard diet (black line) and the five participants starting with the modified diet (red line).
When switching from the standard to the modified diet, serum potassium decreased by -0.84 mmol/L (95% CI: -1.41, -0.27) and -0.68 mmol/L (95% CI -1.25, -0.103), at the three- and four-hour post-meal time points, respectively ( Table 2 and Figure 4). Nine samples were recorded with serum potassium > 6.0 mmol/L and were classified as hyperkalaemic. Of these, eight were from participants while on the standard diet ( Figure 7). This hyperkalaemia was transient with no participant remaining hyperkalaemic the following day pre dialysis. While consumed dietary potassium intakes were similar on both the modified and standard diets, serum potassium was stable or reduced following consumption of the modified meal and steadily increased for 3 hours after consumption of the standard meal ( Figure 4). Individual level biochemical and dietary intake data is available online at the Open Science Framework 45 .
Figure 7. Serum potassium levels.
Figure 7 maps serum potassium on each diet standard (S) in black and modified in red (M) at 6 time points pre-prandial, 1, 2, 3 and 4 hours after the meal and pre dialysis the following day. Five participants had a potassium reading of > 6.0 mmol/L (dashed line) during the study timeframe. Eight of the nine elevated readings were recorded in the standard diet cycle of the study.
The food composition tables provided a similar estimate of phosphorus content to chemical analysis for the standard diet food samples whereas the food composition tables overestimated phosphorus by 37 mg/ day for the modified diet food samples (p < 0.001, 95% CI 24,51) ( Figure 8).
Figure 8. Laboratory analysis versus food composition table estimates.
Difference in food composition table reading minus public lab reading. On the standard diet the food tables estimate of daily intake were similar to the laboratory analysis (p= 0.148) while on the modified diet the food table overestimated the phosphorus content by 37.4mg/day (p= 0.008).
Discussion
In this study consumed dietary intake of phosphorus was lower on the modified low phosphorous diet, while dietary potassium and protein intakes were similar in both diets. Both serum phosphate and serum potassium were reduced at 3 and 4 hours on the modified.
Focusing firstly on serum phosphate, the observed lower serum phosphate is consistent with the decreased dietary phosphorus load consumed in the modified diet, because it contained foods with lower phosphorus to protein ratios. In addition the food matrix, specifically the lower bioavailability of phosphorus from the phytate sources of pulses and nuts, will likely have contributed to reduced absorption of phosphorus and the observed lower serum phosphate 11, 24 . Other factors that may have influenced serum phosphate were circadian pattern and mineral and bone disease status. Physiologically, serum phosphate has a circadian pattern 12– 16 although the responsible mechanisms are poorly understood 46 . However in the study circadian patterns were controlled, as food was served at the same time on each trial day and therefore we do not believe this unduly influenced the comparison of the standard and modified low phosphorus diet. Similarly, whilst mineral and bone disease status can also affect serum phosphate levels, baseline levels indicate that tertiary hyperparathroidism should not have unduly influenced the results and each participant consumed both diets with an adequate washout period, thus controlling for this variable.
We demonstrated that whole food as distinct from phosphate supplements can affect phosphate in the postprandial phase. There are a limited number of small studies in this field. In a recent study by Lundin et al. in 12 HD patients, a meal with high phosphorus content did not significantly affect plasma phosphate compared to a meal with low phosphorus content 47 . Isakova et al. examined the difference between 2 whole-food meals of 250 mg and 500 mg of phosphorus content in 13 patients with CKD stage 3 to 4, and observed that serum phosphate decreased after both meals. In a feeding study on 30 HD patients, a meal containing 1g calcium and 2g phosphorus as a phosphorus supplement, did not increase postprandial serum phosphate 22 . Preliminary experiments by Brown et al. with whole food failed to result in significant increases in serum phosphate, however, when a drink with a phosphorus supplement (1280mg) was used , serum phosphate was significantly increased at 2 and 4 hours (n=8) 23 . Our results support the finding by Ix et al. 14 in 11 CKD patients that whole food intake can affect serum phosphate. In a longer study that included post prandial observations on the final day, Moe et al. demonstrated a vegetarian diet in 9 patients with advanced CKD led to lower serum phosphorus levels than a meat based diet 48 .
Two questions emerge as we consider the results of our study and similar studies, firstly the effect of timing of the intervention on post prandial blood levels and secondly the relative importance of post prandial versus fasting levels. The timing of the intervention may have greater than previous appreciated effect on the serum phosphate levels. The first three studies which were negative were conducted in the morning 22, 47, 49 . The study by Brown et al. was conducted in the morning and failed to show results with solid foods but did lead to an increase in serum phosphate with a large dose of a phosphate supplement 23 . Both Ix et al and Moe et al monitored bloods for 24 hours and demonstrated greater change and greater response of serum phosphate to diet in the afternoon 14 or evening 48 . We demonstrated that food intake can alter serum phosphate in the afternoon. Given that serum phosphate exhibits a marked circadian rhythm, with a peak around 3:00 am and a nadir around 11:00 am 50 , we suggest that this nadir may mask the effect of dietary phosphorus load in the morning.
This leads to a second related question namely the relative importance of post prandial versus fasting levels of serum phosphate. Our study focused on the effect of diet on post-prandial serum phosphate. In healthy populations dietary phosphorus load causes serum phosphate to rise 15, 17, 18, 51– 53 but does not affect subsequent fasting levels 15, 19, 53 with the exception of cheese in one study 53 . Similarly in the CKD population fasting serum phosphate levels have been shown to be a poor indicator of phosphorus load 14 even though fasting levels may be a more reliable predictor of mortality 54, 55 .
Potential mechanisms of harm have been identified for both non-fasting and fasting serum phosphates. A phosphorus load that induces postprandial hyperphosphataemia impairs endothelial function 17, 18 while a phosphorus load sufficient to raise subsequent fasting phosphate, significantly increases blood pressure and pulse 56 . While experts suggest research efforts should be focused on altering fasting levels which may be most harmful 57 , there is still merit in focusing on postprandial measures where effects of diet are more evident 14 and where we have an identified potential mechanisms of harm 17, 18 . Our study did not collect subsequent fasting levels but did collect a pre dialysis sample the following day that was not significantly different between the groups. Whilst we need a better understanding of the relative clinical and prognostic importance of fasting versus postprandial versus pre dialysis serum phosphate, this study provides us with some insight into the effect of diet on the post prandial period and demonstrates the potential weakness of pre dialysis measures of serum phosphate which are often taken early morning or at lunch time and are routinely used to guide clinical treatment. Our finding in the context of similar studies also suggest that future studies should be carried out in the afternoon.
Despite similar dietary potassium intakes on the standard and modified diet, serum potassium was reduced at 3 and 4 hours post-meal consumption in participants who consumed our modified low phosphorus diet compared with the standard low phosphorus diet. This suggests that the food matrix of the modified diet foods may also reduce the absorption of potassium. There is limited evidence from animal studies the phytate content may reduce potassium absorption 58 . Whilst potassium absorption is poorly understood, it has been suggested that the higher potassium load of plant-rich diets may be offset by biological factors affecting potassium metabolism and that dietary fiber may reduce potassium absorption 59 . We also observed a transient hyperkalaemia in five participants on the standard diet during the postprandial period that had resolved by the time a pre dialysis sample was taken the following day ( Figure 7). This is of significance as we rarely check postprandial potassium levels and might underestimate the magnitude of the postprandial spike. This result also indicates that caution may be required in permitting patients to save their dietary allowances for one meal, as with special occasions, and it may be more prudent to spread allowances over the day, from both a protein utilisation and potassium load safety viewpoint 60 .
In this study, the food composition tables overestimated the phosphorus content of the low phosphorus modified diet in comparison to direct analysis and similarly estimated the phosphorus content of the standard diet ( Figure 8). This conflicts with concerns among renal health care professionals that food composition tables underestimate the phosphorus content of foods. This may be partially explained by the fact that most of the food consumed in this study was fresh and unprocessed and the concern from renal healthcare professionals is largely focused on processed foods. In keeping with a study by Tsai et al., 61 our results, provide reassurance regarding the reasonable reliability and accuracy of food composition tables, especially with regard to unprocessed foods.
There were some limitations to this study including a small sample size, gender imbalance and short duration. There was unexpected pronounced difference between the baseline pre-prandial phosphate levels of participants when assigned to the modified and the standard diet, a potential issue for any highly variable parameter with a small sample size. The differences in phosphate levels may have occurred simply due to sampling variability, given the small sample size and substantial variability in the within subject serum phosphate level, which we demonstrate in a post hoc review of the routine dialysis bloods of the study participants before and after the study ( Figure 6) and as reported by other studies 62, 63 . However this variability should not substantially impact on the additional effect of diet relative to the measured baseline, especially in the setting of a short term follow-up of serum phosphate levels in the immediate postprandial hours, where the environment, type and timing of the food, biochemical assays and medications were all strictly controlled. A strength of this study is that it was conducted in a highly controlled setting, with a defined diet and timed regular blood draws. A second strength is that we tested foods and normal meals from our current standard low phosphorus diet and compared it to foods from a proposed modified low phosphorus diet.
This feeding study supported the postprandial safety and tolerability of the modified versus the standard diet, and allowed for further evaluation of the modified diet a randomised controlled trial of 74 patients over one month which concluded that the diet was well tolerated and was associated with similar phosphate and potassium control but with a wider food choice and greater fiber intake than the standard diet 64 . This feeding study should be repeated, with larger numbers in the afternoon or evening. With numbers of people worldwide with kidney disease estimated at 850 million 65 , and limited evidence to guide our practice 10, 66 we need to continue to undertake clinical trials in the field of nutrition to help our understanding of the effects of diet in CKD 59, 67 .
Conclusion
Our understanding of gastrointestinal absorption of phosphorus is surprisingly limited and requires further investigation. The modified diet included more wholegrains, pulses and nuts with lower phosphorus bioavailability, food choices with a lower phosphorus to protein ratio and the avoidance of all phosphate additives. On the modified diet, the serum phosphate and potassium levels were significantly lower at 3 and 4 hours postprandial suggesting reduced absorption of these nutrients.
Data availability
Underlying data
Open Science Framework: The Effect of a Dietary Phosphorus Load and Food Matrix Change in a Controlled One Day Feeding Trial. https://doi.org/10.17605/OSF.IO/M3AUQ 45 .
This project contains the following underlying data:
-
-
Data_dictionary.csv
-
-
Diets.csv
-
-
Main_data.csv
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Acknowledgements
We would like to acknowledge and thank Richard Browne and the staff of the Catering Department at the Mercy University Hospital, who provided the study food, Geraldine Scannell, Clinical Nurse Manager for her invaluable assistance on the study days especially with blood draws and Mary Stapleton, Principal Biochemist and the staff of the Biochemistry Department at Cork University Hospital who analysed the blood samples.
Funding Statement
The author(s) declared that no grants were involved in supporting this work.
[version 1; peer review: 2 approved]
References
- 1. Gutierrez OM, Mannstadt M, Isakova T, et al. : Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584–592. 10.1056/NEJMoa0706130 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Block GA, Klassen PS, Lazarus JM, et al. : Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208–2218. 10.1097/01.ASN.0000133041.27682.A2 [DOI] [PubMed] [Google Scholar]
- 3. Bellasi A, Mandreoli M, Baldrati L, et al. : Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction. Clin J Am Soc Nephrol. 2011;6(4):883–891. 10.2215/CJN.07810910 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Abramowitz M, Muntner P, Coco M, et al. : Serum Alkaline Phosphatase and Phosphate and Risk of Mortality and Hospitalization. Clin J Am Soc Nephrol. 2010;5(6):1064–1071. 10.2215/CJN.08621209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Dhingra R, Sullivan LM, Fox CS, et al. : Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167(9):879–885. 10.1001/archinte.167.9.879 [DOI] [PubMed] [Google Scholar]
- 6. Chang AR, Lazo M, Appel LJ, et al. : High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr. 2014;99(2):320–7. 10.3945/ajcn.113.073148 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Tonelli M, Sacks F, Pfeffer M, et al. : Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease. Circulation. 2005;112(17):2627–33. 10.1161/CIRCULATIONAHA.105.553198 [DOI] [PubMed] [Google Scholar]
- 8. Foley RN, Collins AJ, Ishani A, et al. : Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008;156(3):556–563. 10.1016/j.ahj.2008.05.016 [DOI] [PubMed] [Google Scholar]
- 9. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;76(S113):S1–S130. 10.1038/ki.2009.188 [DOI] [PubMed] [Google Scholar]
- 10. Liu Z, Su G, Guo X, et al. : Dietary interventions for mineral and bone disorder in people with chronic kidney disease. Cochrane Database Syst Rev. 2015; (9):CD010350. 10.1002/14651858.CD010350.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Schlemmer U, Frølich W, Prieto RM, et al. : Phytate in foods and significance for humans: Food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res. 2009;53 Suppl 2(S2):S330–S375. 10.1002/mnfr.200900099 [DOI] [PubMed] [Google Scholar]
- 12. Kemp GJ, Blumsohn A, Morris BW: Circadian changes in plasma phosphate concentration, urinary phosphate excretion, and cellular phosphate shifts. Clin Chem. 1992;38(3): 400–2. [PubMed] [Google Scholar]
- 13. Trivedi H, Szabo A, Zhao S, et al. : Circadian variation of mineral and bone parameters in end-stage renal disease. J Nephrol. 2015;28(3):351–359. 10.1007/s40620-014-0124-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Ix JH, Anderson CAM, Smits G, et al. : Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study. Am J Clin Nutr. 2014;100(5):1392–1397. 10.3945/ajcn.114.085498 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Portale AA, Halloran BP, Morris RC, Jr: Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest. 1987;80(4):1147–1154. 10.1172/JCI113172 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Isakova T, Xie H, Barchi-Chung A, et al. : Daily Variability in Mineral Metabolites in CKD and Effects of Dietary Calcium and Calcitriol. Clin J Am Soc Nephrol. 2012;7(5):820–828. 10.2215/CJN.11721111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Shuto E, Taketani Y, Tanaka R, et al. : Dietary Phosphorus Acutely Impairs Endothelial Function. J Am Soc Nephrol. 2009;20(7):1504–1512. 10.1681/ASN.2008101106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Nishi T, Shuto E, Ogawa M, et al. : Excessive dietary phosphorus intake impairs endothelial function in young healthy men: a time- and dose-dependent study. J Med Invest. 2015;62(3–4):167–172. 10.2152/jmi.62.167 [DOI] [PubMed] [Google Scholar]
- 19. Trautvetter U, Jahreis G, Kiehntopf M, et al. : Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study. Nutr J. 2016;15(1):7. 10.1186/s12937-016-0125-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Vorland CJ, Lachcik PJ, Aromeh LO, et al. : Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats. PLoS One. 2018;13(11):e0207601. 10.1371/journal.pone.0207601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Stremke ER, Hill Gallant KM: Intestinal Phosphorus Absorption in Chronic Kidney Disease. Nutrients. 2018;10(10):1364. 10.3390/nu10101364 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Graziani G, Badalamenti S, Como G, et al. : Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron. 2002;91(3):474–479. 10.1159/000064290 [DOI] [PubMed] [Google Scholar]
- 23. Brown AJ, Koch MJ, Coyne DW: Oral Feeding Acutely Down-Regulates Serum PTH in Hemodialysis Patients. Nephron Clin Pract. 2006;103(3):c106–c113. 10.1159/000092019 [DOI] [PubMed] [Google Scholar]
- 24. Byrne FN, Gillman B, Kiely M, et al. : Revising Dietary Phosphorus Advice in Chronic Kidney Disease G3-5D. J Ren Nutr. 2021;31(2):132–143. 10.1053/j.jrn.2020.04.003 [DOI] [PubMed] [Google Scholar]
- 25. Byrne FN, Gillman B, Kiely M, et al. : Translation of Nutrient Level Recommendations to Control Serum Phosphate Into Food-Based Advice. J Ren Nutr. 2021;31(1):43–48. 10.1053/j.jrn.2020.04.005 [DOI] [PubMed] [Google Scholar]
- 26. Avesani CM, Teta D, Carrero JJ: Liberalizing the diet of patients undergoing dialysis: are we ready? Nephrol Dial Transplant. 2019;34(2):180–183. 10.1093/ndt/gfy309 [DOI] [PubMed] [Google Scholar]
- 27. Kalantar-Zadeh K, Tortorici AR, Chen JLT, et al. : Dietary Restrictions in Dialysis Patients: Is There Anything Left to Eat? Semin Dial. 2015;28(2):159–168. 10.1111/sdi.12348 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Chauveau P, Koppe L, Combe C, et al. : Vegetarian diets and chronic kidney disease. Nephrol Dial Transplant. 2019;34(2):199–207. 10.1093/ndt/gfy164 [DOI] [PubMed] [Google Scholar]
- 29. Cases A, Cigarran-Guldris S, Mas S, et al. : Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider. Nutrients. 2019;11(6):1263. 10.3390/nu11061263 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Byrne FN, Calvo MS: Pulses and Chronic Kidney Disease: Potential Health Benefits from a Once forbidden Food. In: Dahl JD, ed. Health Benefits of Pulses. Switzerland: Springer,2019;73–90. 10.1007/978-3-030-12763-3_6 [DOI] [Google Scholar]
- 31. Daly JA, Ertingshausen G: Direct Method for Determining Inorganic Phosphate in Serum with the "CentrifiChem". Clin Chem. 1972;18(3):263–265. 10.1093/clinchem/18.3.263 [DOI] [PubMed] [Google Scholar]
- 32. Gamst O, Try K: Determination of serum-phosphate without deproteinization by ultraviolet spectrophotometry of the phosphomolybdic acid complex. Scand J Clin Lab Invest. 1980;40(5):483–486. 10.3109/00365518009101872 [DOI] [PubMed] [Google Scholar]
- 33. Tietz N, Pruden E, Siggaard-Anderson O: Electrolytes.In: Tietz NW, Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. 2nd ed. / ed. Philadelphia: Saunders,1994;614–624. [Google Scholar]
- 34. Abbott Laboratories: ARCHITECT Intact PTH Package insert instructions 8K25-28, 8K25-21.Barcelona,2017. [Google Scholar]
- 35. Renal Interest Group of Irish Nutrition & Dietetic Institute: Eating Well with Kidney Disease.In: Irish Nutrition & Dietetic Institute. ed. Dublin,2010. [Google Scholar]
- 36. Nutritics Nutrional Analysis Software.[computer program]. Version Research Edition v5.028. Dublin,2017. [Google Scholar]
- 37. Public Health England: McCance and Widdowson's composition of foods integrated dataset.London,2015. Reference Source [Google Scholar]
- 38. Bower JA: Cooking for restricted potassium diets in dietary treatment of renal patients. J Hum Nutr Diet. 1989;2(1):31–38. 10.1111/j.1365-277X.1989.tb00005.x [DOI] [Google Scholar]
- 39. Bethke PC, Jansky SH: The effects of boiling and leaching on the content of potassium and other minerals in potatoes. J Food Sci. 2008;73(5):H80–85. 10.1111/j.1750-3841.2008.00782.x [DOI] [PubMed] [Google Scholar]
- 40. Pradhan S, Pokhrel MR: Spectrophotometric Determination of Phosphate in Sugarcane Juice, Fertilizer, Detergent and Water Samples by Molybdenum Blue Method. Scientific World. 2013;11(11):58–62. Reference Source [Google Scholar]
- 41. Whitehead AL, Sully BG, Campbell MJ: Pilot and feasibility studies: is there a difference from each other and from a randomised controlled trial? Contemp Clin Trials. 2014;38(1):130–133. 10.1016/j.cct.2014.04.001 [DOI] [PubMed] [Google Scholar]
- 42. Bates D, Mächler M, Bolker B, et al. : Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015;67(1):1–48. 10.18637/jss.v067.i01 [DOI] [Google Scholar]
- 43. Hothorn T, Bretz F, Westfall P, et al. : multcomp: Simultaneous Inference in General Parametric Models.2020;1.4–15. Reference Source [DOI] [PubMed] [Google Scholar]
- 44. The R Project for Statistical Computing.[computer program]:2020. Reference Source [Google Scholar]
- 45. Palmer B: The Effect of a Dietary Phosphorus Load and Food Matrix Change in a Controlled One Day Feeding Trial.2021. 10.17605/OSF.IO/M3AUQ [DOI] [Google Scholar]
- 46. Isakova T, Block G: The phosphate bucket list. Kidney Int. 2018;93(5):1033–1035. 10.1016/j.kint.2018.01.010 [DOI] [PubMed] [Google Scholar]
- 47. Lundin MT, Bressendorff I, Kristensen B, et al. : Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis. Kidney Int Rep. 2021;6(2):304–312. 10.1016/j.ekir.2020.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Moe SM, Zidehsarai MP, Chambers MA, et al. : Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2011;6(2):257–264. 10.2215/CJN.05040610 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Isakova T, Gutierrez O, Shah A, et al. : Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD. J Am Soc Nephrol. 2008;19(3):615–623. 10.1681/ASN.2007060673 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Barreto FC, Barreto DV, Massy ZA, et al. : Strategies for Phosphate Control in Patients With CKD. Kidney Int Rep. 2019;4(8):1043–1056. 10.1016/j.ekir.2019.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Bell RR, Draper HH, Tzeng DY, et al. : Physiological Responses of Human Adults to Foods Containing Phosphate Additives. J Nutr. 1977;107(1):42–50. 10.1093/jn/107.1.42 [DOI] [PubMed] [Google Scholar]
- 52. Kawamura H, Tanaka S, Ota Y, et al. : Dietary intake of inorganic phosphorus has a stronger influence on vascular-endothelium function than organic phosphorus. J Clin Biochem Nutr. 2018;62(2):167–173. 10.3164/jcbn.17-97 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Karp HJ, Vaihia KP, Karkkainen MUM, et al. : Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach. Calcif Tissue Int. 2007;80(4):251–8. 10.1007/s00223-007-9011-7 [DOI] [PubMed] [Google Scholar]
- 54. Chang AR, Grams ME: Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. Am J Kidney Dis. 2014;64(4):567–573. 10.1053/j.ajkd.2014.04.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Vervloet MG, Sezer S, Massy ZA, et al. : The role of phosphate in kidney disease. Nat Rev Nephrol. 2017;13(1):27–38. 10.1038/nrneph.2016.164 [DOI] [PubMed] [Google Scholar]
- 56. Mohammad J, Scanni R, Bestmann L, et al. : A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects. J Am Soc Nephrol. 2018;29(8):2089–2098. 10.1681/ASN.2017121254 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Vervloet MG, van Ballegooijen AJ: Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 2018;93(5):1060–1072. 10.1016/j.kint.2017.11.036 [DOI] [PubMed] [Google Scholar]
- 58. Woyengo TA, Cowieson AJ, Adeola O, et al. : Ileal digestibility and endogenous flow of minerals and amino acids: responses to dietary phytic acid in piglets. Br J Nutr. 2009;102(3):428–433. 10.1017/S0007114508184719 [DOI] [PubMed] [Google Scholar]
- 59. St-Jules DE, Fouque D: Is it time to abandon the nutrient-based renal diet model? Nephrol Dial Transplant. 2021;36(4):574–577. 10.1093/ndt/gfaa257 [DOI] [PubMed] [Google Scholar]
- 60. St-Jules DE, Goldfarb DS, Pompeii ML, et al. : Assessment and misassessment of potassium, phosphorus, and protein in the hemodialysis diet. Semin Dial. 2018;31(5):479–486. 10.1111/sdi.12713 [DOI] [PubMed] [Google Scholar]
- 61. Tsai WC, Peng YS, Wu HY, et al. : Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets. Sci Rep. 2018;8(1):15246. 10.1038/s41598-018-33657-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Damasiewicz MJ, Lu ZX, Kerr PG, et al. : The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort. BMC Nephrol. 2018;19(1):325. 10.1186/s12882-018-1127-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Zhu M, Dou L, Liu S, et al. : Variability of serum phosphorus and its association with mortality among hemodialysis patients. Clin Nephrol. 2018;90(2):79–86. 10.5414/CN109265 [DOI] [PubMed] [Google Scholar]
- 64. Byrne F, Gillman BA, Kiely M, et al. : Pilot Randomized Controlled Trial of a Standard versus a Modified Low-Phosphorus Diet in Hemodialysis Patients. Kidney Int Rep. 2020;5(11):1945–1955. 10.1016/j.ekir.2020.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Jager KJ, Kovesdy C, Langham R, et al. : A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048–1050. 10.1016/j.kint.2019.07.012 [DOI] [PubMed] [Google Scholar]
- 66. St-Jules DE, Rozga MR, Handu D, et al. : Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2021;16(1):107–120. 10.2215/CJN.09360620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Bover J, Molina P, Ureña-Torres P, et al. : Feasible Low-Phosphorus Dietary Patterns in Maintenance Hemodialysis Patients: Need for Original Research. Kidney Int Rep. 2020;5(11):1845–1847. 10.1016/j.ekir.2020.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]






